(Q42712712)

English

A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons

scientific article published on March 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

A DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine, exacerbates neurotoxicity and upregulates Parkinson's disease-related genes in dopaminergic neurons (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

Yong Wang

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Xuan Wang

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Ran Li

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Zhao-Fei Yang

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Yi-Zheng Wang

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Xiao-Li Gong

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Xiao-Min Wang

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

CNS Neuroscience & Therapeutics

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

183-190

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Epigenetics in the nervous system

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Epigenetic principles and mechanisms underlying nervous system functions in health and disease

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Phenotypic plasticity and the epigenetics of human disease

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Environmental epigenomics and disease susceptibility

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation.

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Epigenetic dysregulation in cognitive disorders.

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Epigenetic regulation in psychiatric disorders

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Epigenetics in human disease and prospects for epigenetic therapy

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Parkinson's disease: mechanisms and models

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Ageing and neuronal vulnerability

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Apoptosis in Parkinson's disease: signals for neuronal degradation

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Methylation regulates alpha-synuclein expression and is decreased in Parkinson's disease patients' brains.

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Reelin promoter hypermethylation in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Genetic clues to the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

The role of alpha-synuclein in Parkinson's disease: insights from animal models

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

The tissue-specific methylation of the human tyrosine hydroxylase gene reveals new regulatory elements in the first exon

1 reference

https://api.crossref.org/works/10.1111%2FCNS.12059

21 January 2018

Gene silencing through methylation: an epigenetic intervention on Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23441691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clues to how alpha-synuclein damages neurons in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23441691

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CNS.12059

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493528&resulttype=core&format=json

14 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42712712&oldid=2186260985"